Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta‑analysis

Li,Hui; Fu,Wei‑Ping; Hong,Ze‑Hui

doi:10.3892/ol.2012.1099

Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta‑analysis

Authors:
- Hui Li
- Wei‑Ping Fu
- Ze‑Hui Hong
View Affiliations

Affiliations: Department of Genetics and Developmental Biology, Southeast University School of Medicine, Nanjing 210009, P.R. China, Department of Respiratory Critical Care Medicine, The First Affiliated Hospital of Kunming Medical College, Kunming 650091, P.R. China
Published online on: December 28, 2012 https://doi.org/10.3892/ol.2012.1099
Pages: 1022-1030

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Microsomal epoxide hydrolase (EPHX1) is an enzyme involved in the detoxification the products of smoking and is proposed to be a genetic factor for the development of chronic obstructive pulmonary disease (COPD). Two functional polymorphisms of EPHX1, T113C and A139G, have been analyzed in numerous studies to assess the COPD risk attributed to these variants. However, the conclusions were controversial. We performed a comprehensive meta‑analysis to clarify these findings. A total of 24 studies comprising 8,259 COPD patients and 42,883 controls were included. The overall results showed that the EPHX1 113 mutant homozygote was significantly associated with an increased risk of COPD (OR, 1.33; 95% CI, 1.06‑1.69). The subgroup analyses demonstrated this association in Caucasian individuals (OR, 1.61; 95% CI, 1.12‑2.31) but not in Asian individuals. The 139 mutant heterozygote was significantly associated with a decreased risk of COPD in Asian populations (OR, 0.82; 95% CI, 0.68‑0.99) but not in Caucasian populations. Pooled analyses revealed that the extremely slow (OR, 1.77; 95% CI, 1.23‑2.55) and slow EPHX1 enzyme activity (OR, 1.44; 95% CI, 1.13‑1.85) were associated with an increased risk of COPD, while the fast enzyme activity was not associated with a decreased risk of COPD. The stratified analysis demonstrated this association in Caucasian but not in Asian individuals. Furthermore, a modest difference in the risk of COPD was observed between the subgroups by using the cigarette smokers or the non‑smokers as controls. A significant correlation between the two functional polymorphisms, T113C and A139G, of the EPHX1 gene and the enzyme activity and the individual's susceptibility to COPD was noted. In addition, the results supported a contribution of EPHX1 to the aetiology of COPD.

View Figures

View References

1	Pauwels RA, Buist AS, Calverley PM, Jenkins CR and Hurd SS; GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 163:1256–1276. 2001. View Article : Google Scholar
2	Fabbri L, Caramori G, Beghe B, Papi A and Ciaccia A: Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med. 4:76–84. 1998. View Article : Google Scholar : PubMed/NCBI
3	Løkke A, Lange P, Scharling H, Fabricius P and Vestbo J: Developing COPD: a 25 year follow up study of the general population. Thorax. 61:935–939. 2006.PubMed/NCBI
4	Silverman EK, Chapman HA, Drazen JM, et al: Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 157:1770–1778. 1998. View Article : Google Scholar
5	Foreman MG, DeMeo DL, Hersh CP, Reilly JJ and Silverman EK: Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J. 30:1124–1130. 2007. View Article : Google Scholar : PubMed/NCBI
6	Oesch F, Glatt H and Schmassmann H: The apparent ubiquity of epoxide hydratase in rat organs. Biochem Pharmacol. 26:603–607. 1977. View Article : Google Scholar : PubMed/NCBI
7	Omiecinski CJ, Aicher L, Holubkov R and Checkoway H: Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics. 3:150–158. 1993. View Article : Google Scholar : PubMed/NCBI
8	Hassett C, Aicher L, Sidhu JS and Omiecinski CJ: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 3:421–428. 1994. View Article : Google Scholar : PubMed/NCBI
9	Smith CA and Harrison DJ: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 350:630–633. 1997. View Article : Google Scholar : PubMed/NCBI
10	Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N and Kamakami Y: Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur Respir J. 15:891–894. 2000. View Article : Google Scholar : PubMed/NCBI
11	Yim JJ, Park GY, Lee CT, et al: Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax. 55:121–125. 2000. View Article : Google Scholar
12	Rodriguez F, Jardi R, Costa X, et al: Detection of polymorphisms at exons 3 (Tyr113-->His) and 4 (His139-->Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem. 308:120–126. 2002.PubMed/NCBI
13	Korytina GF, Ianbaeva DG and Viktorova TV: Role of polymorphic variants of cytochrome P450 genes (CYP1A1, CYP2E1) and microsomal epoxide hydrolase (mEPHX) in pathogenesis of cystic fibrosis and chronic respiratory tract diseases. Mol Biol (Mosk). 37:784–792. 2003.(In Russian).
14	Cheng SL, Yu CJ, Chen CJ and Yang PC: Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J. 23:818–824. 2004. View Article : Google Scholar : PubMed/NCBI
15	Xiao D, Wang C, Du MJ, et al: Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin Med J (Engl). 117:661–667. 2004.
16	Hersh CP, Demeo DL, Lange C, et al: Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol. 33:71–78. 2005. View Article : Google Scholar : PubMed/NCBI
17	Brøgger J, Steen VM, Eiken HG, Gulsvik A and Bakke P: Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J. 27:682–688. 2006.PubMed/NCBI
18	Fu WP, Sun C, Dai LM, Yang LF and Zhang YP: Relationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese population. Oncol Rep. 17:483–488. 2007.PubMed/NCBI
19	Vibhuti A, Arif E, Deepak D, Singh B and Qadar Pasha MA: Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Biochem Biophys Res Commun. 359:136–142. 2007. View Article : Google Scholar : PubMed/NCBI
20	Zhang RB, Zhang AZ, He QY and Lu BB: Microsomal epoxide hydrolase gene polymorphism and susceptibility to chronic obstructive pulmonary disease in Han nationality of North China. Zhonghua Nei Ke Za Zhi. 41:11–14. 2002.(In Chinese).
21	Zheng Q and Zheng W: The association between the microsomal epoxide hydrolase gene polymorphism and host’s susceptibility to COPD. Chin J Prim Med Pham (Chin). 16:1779–1780. 2009.(In Chinese).
22	Zidzik J, Slabá E, Joppa P, et al: Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J. 49:182–191. 2008. View Article : Google Scholar : PubMed/NCBI
23	Chappell S, Daly L, Morgan K, et al: Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J. 32:931–937. 2008. View Article : Google Scholar : PubMed/NCBI
24	Lakhdar R, Denden S, Knani J, et al: Microsomal epoxide hydrolase gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in the Tunisian population. Genet Test Mol Biomarkers. 14:857–863. 2010. View Article : Google Scholar : PubMed/NCBI
25	Penyige A, Poliska S, Csanky E, et al: Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. BMC Med Genet. 11:1522010. View Article : Google Scholar : PubMed/NCBI
26	Lee J, Nordestgaard BG and Dahl M: EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis. Eur Respir J. 37:18–25. 2011. View Article : Google Scholar : PubMed/NCBI
27	Chen CZ, Wang RH, Lee CH, Lin CC, Chang HY and Hsiue TR: Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response. J Formos Med Assoc. 110:685–689. 2011. View Article : Google Scholar : PubMed/NCBI
28	Budhi A, Hiyama K, Isobe T, et al: Genetic susceptibility for emphysematous changes of the lung in Japanese. Int J Mol Med. 11:321–329. 2003.PubMed/NCBI
29	Park JY, Chen L, Wadhwa N and Tockman MS: Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int J Mol Med. 15:443–448. 2005.PubMed/NCBI
30	Yoshikawa M, Hiyama K, Ishioka S, Maeda H, Maeda A and Yamakido M: Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med. 5:49–53. 2000.PubMed/NCBI
31	Matheson MC, Raven J, Walters EH, Abramson MJ and Ellis JA: Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol. 78:705–717. 2006. View Article : Google Scholar : PubMed/NCBI
32	Park SS, Kim EJ, Son CY, et al: Genetic polymorphism of epoxide hydrolase and GSTM1 in chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul). 55:88–97. 2003.
33	Hu G, Shi Z, Hu J, Zou G, Peng G and Ran P: Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses. Respirology. 13:837–850. 2008. View Article : Google Scholar : PubMed/NCBI
34	Cochran WG: The combination of estimates from different experiments. Biometrics. 10:101–129. 1954. View Article : Google Scholar
35	Kavvoura FK and Ioannidis JP: Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet. 123:1–14. 2008. View Article : Google Scholar : PubMed/NCBI
36	Colhoun HM, McKeigue PM and Davey Smith G: Problems of reporting genetic associations with complex outcomes. Lancet. 361:865–872. 2003. View Article : Google Scholar : PubMed/NCBI
37	Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
38	DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials. 7:177–188. 1986. View Article : Google Scholar : PubMed/NCBI
39	Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI
40	Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
41	Zhou W, Thurston SW, Liu G, et al: The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev. 10:461–466. 2001.
42	Maekawa K, Itoda M, Hanioka N, et al: Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects. Xenobiotica. 33:277–287. 2003. View Article : Google Scholar : PubMed/NCBI
43	Smolonska J, Wijmenga C, Postma DS and Boezen HM: Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years’ research. Am J Respir Crit Care Med. 180:618–631. 2009.